Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 58,292 | 38,314 | 41,287 | 236,974 | 0 |
| Operating Income | -58,246 | -38,314 | -41,287 | -237,020 | N/A |
| Interest Expense | 1,281 | -65 | -27 | -8 | 0 |
| Other Income | -1,962 | -1,906 | -191 | -1,679 | 0 |
| Pre-tax Income | -61,489 | -40,155 | -41,451 | -238,691 | 0 |
| Net Income Continuous | -61,603 | -40,155 | -41,451 | -238,691 | N/A |
| Net Income | $-61,603 | $-40,155 | $-41,451 | $-238,691 | $N/A |
| EPS Basic Total Ops | 0.99 | -0.45 | -0.65 | -4.97 | N/A |
| EPS Basic Continuous Ops | 0.99 | -0.45 | -0.65 | -4.97 | N/A |
| EPS Diluted Total Ops | 0.99 | -0.45 | -0.65 | -4.97 | N/A |
| EPS Diluted Continuous Ops | 0.99 | -0.45 | -0.65 | -4.97 | N/A |
| EBITDA(a) | $-58,280 | $-38,301 | $-41,280 | $-236,972 | $N/A |